Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH)

Tipranks - Tipranks - Sat Feb 7, 7:30AM CST

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IQVIA Holdings (IQV – Research Report) and Molina Healthcare (MOH – Research Report).

Claim 50% Off TipRanks Premium

IQVIA Holdings (IQV)

Truist Financial analyst Jailendra Singh reiterated a Buy rating on IQVIA Holdings today. The company’s shares closed last Thursday at $180.96, close to its 52-week low of $176.03.

According to TipRanks.com, Singh ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -12.5% and a 37.1% success rate. Singh covers the Healthcare sector, focusing on stocks such as Hinge Health, Inc. Class A, Fortrea Holdings Inc., and Medline, Inc. Class A. ;'>

Currently, the analyst consensus on IQVIA Holdings is a Moderate Buy with an average price target of $242.00, which is a 21.1% upside from current levels. In a report released yesterday, BMO Capital also maintained a Buy rating on the stock with a $250.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Molina Healthcare (MOH)

Truist Financial analyst David S Macdonald maintained a Hold rating on Molina Healthcare today. The company’s shares closed last Thursday at $176.84.

According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 11.8% and a 59.5% success rate. Macdonald covers the Healthcare sector, focusing on stocks such as Guardian Pharmacy Services, Inc. Class A, Concentra Group Holdings Parent, Inc., and Ardent Health Partners, Inc. ;'>

Molina Healthcare has an analyst consensus of Hold, with a price target consensus of $189.33, implying a 7.2% upside from current levels. In a report issued on February 3, Guggenheim also maintained a Hold rating on the stock.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).